Tech Focus Asia: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Focus Asia.

Press releases published on May 30, 2026

May 30, 2026

Creality Charts Next Decade as AI-Powered Consumer 3D Creative Platform

Indeterminate EIN Presswire

May 30, 2026

Momcozy สร้างความเชื่อมั่นก่อนตัดสินใจซื้อในกลุ่มคุณแม่เอเชียตะวันออกเฉียงใต้ ต้อนรับแคมเปญ 6.6

Indeterminate EIN Presswire

May 30, 2026

Momcozy Perkuat Kepercayaan Ibu Asia Tenggara Sebelum Berbelanja di Momen 6.6

Indeterminate EIN Presswire

May 30, 2026

Momcozy កំពុងកសាងទំនុកចិត្តមុនពេលទិញក្នុងចំណោមម្ដាយអាស៊ីអាគ្នេយ៍ មុនយុទ្ធនាការ 6.6

Indeterminate EIN Presswire

May 30, 2026

Beyond the Cart: How Momcozy is Securing 'Pre-Checkout Trust' Among Southeast Asian Mothers Ahead of 6.6

Indeterminate EIN Presswire

May 30, 2026

Beyond the Cart: How Momcozy is Securing 'Pre-Checkout Trust' Among Southeast Asian Mothers Ahead of 6.6

Indeterminate EIN Presswire

May 30, 2026

Beyond the Cart: How Momcozy is Securing 'Pre-Checkout Trust' Among Southeast Asian Mothers Ahead of 6.6

Indeterminate EIN Presswire

May 30, 2026

Beyond the Cart: How Momcozy is Securing 'Pre-Checkout Trust' Among Southeast Asian Mothers Ahead of 6.6

Indeterminate EIN Presswire

May 30, 2026

Orion Pharma announces first results from Phase 1/2 TEADES trial with TEAD inhibitor ODM-212 in patients with advanced solid tumours

Indeterminate GlobeNewswire

May 30, 2026

Orion Pharma julkisti ensimmäiset tulokset Faasi 1/2 TEADES-tutkimuksesta ODM-212-molekyylillä (TEAD-estäjä) potilailla, joilla on kiinteitä kasvaimia ja edennyt syöpä

Indeterminate GlobeNewswire

May 30, 2026

Eikon Therapeutics Presents Data on Clinical-Stage Programs at the 2026 Annual Meeting of the American Society of Clinical Oncology

Indeterminate GlobeNewswire

May 30, 2026

Globale Daten der ROSETTA Lung-02-Studie: Ermutigende Wirksamkeit für BioNTechs und Bristol Myers Squibbs bispezifischen PD-L1xVEGF-A-Immunmodulator-Kandidat Pumitamig bei nicht-kleinzelligem Lungenkrebs

Indeterminate GlobeNewswire

May 30, 2026

Global Data for BioNTech and Bristol Myers Squibb’s PD-L1xVEGF-A Bispecific Pumitamig Shows Encouraging Efficacy in Patients with Non-Small Cell Lung Cancer in ROSETTA Lung-02 Trial

Indeterminate GlobeNewswire

May 30, 2026

ITM Announces Phase 3 COMPETE Patient-Reported Quality of Life Data with n.c.a. ¹⁷⁷Lu-edotreotide (ITM-11) vs. Everolimus at ASCO 2026

Indeterminate GlobeNewswire

May 30, 2026

Mineralys Therapeutics Presents New Data from the Phase 3 Launch-HTN Trial of Lorundrostat in Participants with Hypertension and Chronic Kidney Disease at European Meeting on Hypertension and Cardiovascular Protection (ESH 2026)

Indeterminate GlobeNewswire

May 30, 2026

Vapofil Reviews [URGENT REPORT 2026] The Shocking VapoFil Male Enhancement Supplement Trend Everyone Is Talking About

Indeterminate GlobeNewswire

May 30, 2026

ImPact Biotech Presents Updated Data from Phase 1 Trial of Padeliporfin VTP in LA-PDAC and Phase 3 ENLIGHTED Trial in LG-UTUC at ASCO 2026

Indeterminate GlobeNewswire

May 30, 2026

JELLY TIDE [URGENT REPORT 2026]: The Shocking Rise of JellyTide Gummies—What Consumers Need to Know About the Viral Wellness Trend

Indeterminate GlobeNewswire

May 30, 2026

Immatics Presents Clinical Activity of IMA203CD8 PRAME Cell Therapy in Hard-to-Treat Gynecologic Cancers at 2026 ASCO Annual Meeting

Indeterminate GlobeNewswire

May 30, 2026

Cogent Biosciences Announces Detailed Clinical Data from PEAK Phase 3 Trial with Bezuclastinib in Combination with Sunitinib in Gastrointestinal Stromal Tumors (GIST) at 2026 American Society of Clinical Oncology (ASCO) Annual Meeting

Indeterminate GlobeNewswire